C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.

[1]  N. Santelmo,et al.  N2-IIIA non-small cell lung cancer: a plea for surgery! , 2016, Journal of thoracic disease.

[2]  Y. Maehara,et al.  Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer. , 2016, Lung cancer.

[3]  H. Asamura,et al.  Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Jae Min Lee,et al.  Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. , 2016, World journal of gastrointestinal oncology.

[5]  Ying Sun,et al.  Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma , 2016, Journal of Cancer.

[6]  J. de-Torres,et al.  The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development. , 2016, Lung cancer.

[7]  Q. Zuo,et al.  The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer , 2016, Tumor Biology.

[8]  M. Higuchi,et al.  Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer. , 2016, Journal of cancer research and therapeutics.

[9]  T. Misawa,et al.  The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection , 2016, World Journal of Surgery.

[10]  K. Hirakawa,et al.  Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer. , 2016, Anticancer research.

[11]  H. Horio,et al.  Neutrophil–Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection , 2016, World Journal of Surgery.

[12]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  S. Natsugoe,et al.  Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma , 2015, Medicine.

[14]  Wei Hu,et al.  A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma , 2015, PloS one.

[15]  Dazhi Xu,et al.  Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer , 2015, Translational oncology.

[16]  M. Hiraoka,et al.  Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. , 2015, International journal of radiation oncology, biology, physics.

[17]  Yurii B. Shvetsov,et al.  Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk , 2015, PloS one.

[18]  Y. Huang,et al.  Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer , 2015, Scientific Reports.

[19]  B. Laird,et al.  Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors. , 2015, Lung cancer.

[20]  Long Bai,et al.  A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio , 2015, BMC Cancer.

[21]  B. Shi,et al.  Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer , 2015, Thoracic cancer.

[22]  K. Koike,et al.  The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.

[23]  A. Marchetti,et al.  Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  J. Debus,et al.  Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis , 2014, BMC Cancer.

[25]  D. Boffa,et al.  Management of clinical stage IIIA primary lung cancers in the National Cancer Database. , 2014, The Annals of thoracic surgery.

[26]  D. Waller,et al.  The N2 paradox: similar outcomes of pre- and postoperatively identified single-zone N2a positive non-small-cell lung cancer. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  M. Kovarik,et al.  Clinically relevant determinants of body composition, function and nutritional status as mortality predictors in lung cancer patients. , 2014, Lung cancer.

[28]  D. McMillan,et al.  Cancer and systemic inflammation: treat the tumour and treat the host , 2014, British Journal of Cancer.

[29]  E. Elinav,et al.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.

[30]  F. Carli,et al.  Summary points and consensus recommendations from the North American Surgical Nutrition Summit. , 2013, JPEN. Journal of parenteral and enteral nutrition.

[31]  D. McMillan.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. , 2013, Cancer treatment reviews.

[32]  Y. M. Moreno,et al.  Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients , 2013, Lipids.

[33]  D. Talwar,et al.  Optimization of the systemic inflammation‐based Glasgow Prognostic Score , 2013, Cancer.

[34]  L. Tanoue,et al.  Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[35]  Marcelo Park,et al.  C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients , 2013, PloS one.

[36]  N. Masuda,et al.  Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A. , 2013, Oncology reports.

[37]  Carsten Denkert,et al.  Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization , 2012, PloS one.

[38]  E. Miyaoka,et al.  Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[39]  A. Egashira,et al.  Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. , 2011, American journal of surgery.

[40]  V. Rusch,et al.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.

[41]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[42]  C. Kelly,et al.  Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. , 2009, Clinical medicine.

[43]  T. Whiteside.  The tumor microenvironment and its role in promoting tumor growth , 2008, Oncogene.

[44]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[45]  C. Foucault,et al.  Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases. , 2007, The Annals of thoracic surgery.

[46]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[47]  C. McArdle,et al.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer , 2007, International Journal of Colorectal Disease.

[48]  P. V. Van Schil,et al.  ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[49]  E. Miyaoka,et al.  Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. , 2005, Lung cancer.

[50]  H. Wada,et al.  Prognostic Factors in Resected Pathologic (p-) Stage IIIA-N2, Non-Small-Cell Lung Cancer , 2004, Annals of Surgical Oncology.

[51]  D C McMillan,et al.  Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer , 2003, British Journal of Cancer.

[52]  Y. Nishiwaki,et al.  The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. , 1999, The Journal of thoracic and cardiovascular surgery.

[53]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[54]  K. Nackaerts,et al.  Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases , 1997 .

[55]  G. Kōsaki,et al.  [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. , 1984, Nihon Geka Gakkai zasshi.

[56]  S. Ida,et al.  Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer , 2013, Journal of Gastroenterology.

[57]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.